Table 2.
Peptidomimetics with anti-biofilm activity at sub-inhibitory concentrations.
Peptidomimetics | MIC (μg.ml−1) | MBIC (μg.ml−1) | Target organism | Mechanism | HC50c (μg.ml−1) | References |
---|---|---|---|---|---|---|
mLys/mPhe | 8 | 8 | P. aeruginosa |
|
260.5 | Vishwakarma et al., 2021 |
mLys/mAla | 16 | 8 | P. aeruginosa |
|
>1,250 | Vishwakarma et al., 2021 |
mArg/mPhe | 4 | 4 | P. aeruginosa |
|
197.5 | Vishwakarma et al., 2021 |
mArg/mAla | 4 | 4 | P. aeruginosa |
|
551.6 | Vishwakarma et al., 2021 |
Nal-P-113 | 160 | 6.25 | P. gingivalis W83 | Downregulation of genes related to binding proteins, transport, motility and transposases | Wang et al., 2017a | |
DJK-5 | 16 | 1a | P. aeruginosa | Degradation of (p)ppGpp | De La Fuente-Núñez et al., 2015 | |
1.6 | 0.8a | E. coli 0157 | ||||
8 | 4a | A. baumannii | ||||
3.2 | 1.6a | K. pneumoniae | ||||
3.2 | 0.8a | S. enterica | ||||
DJK-6 | 16 | 0.5a | P. aeruginosa | Degradation of (p)ppGpp | De La Fuente-Núñez et al., 2015 | |
16 | 8a | E. coli 0157 | ||||
8 | 2a | A. baumannii | ||||
4 | 2a | K. pneumoniae | ||||
4 | 1a | S. enterica | ||||
Ac-Gup-Gup-Nap-Arg-NH2 | >5 mM | 0.08 (mM)b | P. aeruginosa | Sequestering c-di-GMP | Foletti et al., 2018 | |
Ac-Nap-Gup-Gup-Nap-Arg-NH2 | 0.156 mM | 0.02 (mM)b | P. aeruginosa | Sequestering c-di-GMP | Foletti et al., 2018 |
Minimal biofilm inhibitory concentrations leading to 50% decrease in adherent biofilm growth.
Minimal biofilm inhibitory concentrations that inhibited 50% of biofilm growth.
HC50: peptidomimetic concentration that produces 50% of hemolysis.